Zepbound (tirzepatide): This medication is dual-acting, mimicking both GLP-1 and another hormone called Glucose-Dependent Insulinotropic Polypeptide (GIP)
Step 5: Start low, check early begin at a conservative dose and recheck labs or symptoms within 18 weeks depending on the medication in question
A higher exposure to estrogen and/or progesterone might increase the risk for thromboembolism, and a lower exposure might result in failure of birth control [41]
Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F
Patients should separate the timing of these medications and follow their healthcare provider's advice on appropriate dosing intervals
A randomized, placebo-controlled trial further evaluated the effect of exenatide on ICP in women with IIH [99]